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Impact of Simvastatin on Development of New-onset Diabetes Mellitus in Asian
Population: Three-year Clinical Follow up Results
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Background: Although statin therapy is beneﬁcial for vascular diseases, the rela-
tionship between speciﬁc statin therapy and incidence of new-onset diabetes mellitus
(DM)remains uncertain. We evaluated the impact of Simvastatin therapyon the
development of new-onset DM from3-year clinicalfollow up datain a series of Asian
population.
Methods: A total of 3,436 consecutive patients who did not have DM were enrolled.
New-onset DMwas deﬁned as having a fasting blood glucose 126mg/dLor HbA1c
6.5%. Baseline characteristics between the Simvastatin and the control group were
propensity score matched (PSM, C-statics¼0.808). Three-year cumulative incidence
of new-onset DM was compared between the two groups.
Results: At baseline, patients in the Simvastatin group showed higher prevalence
ofelderly, male gender,dyslipidemia, coronary artery disease, smoking and alcoholic
history, and higher levels of HbA1c, fasting glucose, triglyceride, ﬁbrinogen,
and ALP. Three-year clinical follow up results showed a higher incidenceof
new-onset DM in the Simvastatin group (3.8% vs. 2%, p¼0.017). Following PSM
(C-statics¼0.808), the 2 groups were well balanced except for higher levels of
ﬁbrinogen, ALT, and ALP in the Simvastatin group. After adjustment, there was no
difference in the incidence of new-onset DMbetween the 2 groups up to 3years
(Figure).
Conclusion: In our study, the relationship between the use of Simvastatin and the
incidence of new-onset DM remains unclear. Long-term follow up with a larger study
population will be necessary for further information.S58 JACC Vol 63/12/Suppl S jTCTAP A-202
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Background: In-stent stenosis remains one of the most thrilling problems of inter-
ventional cardiology, and the search of the ways of its solution includes the study of
causes andmechanisms of neointimal hyperproliferation. For this reason the study of the
impact of N-acetylation phenotype on the process of restenosis seems very interesting.
Methods: Retrospective study included 100 male patients aged 56,8  6,1 years on
the average, who received 116 coronary BMS for chronic CHD from December 2003
to January 2007. The patients have been selected for the study after control coronary
angiography performed in 7,2  2,2 months after PCI. The main inclusion criterion
was the presence of in-stent stenosis (Group 1, n¼50) and good mid-term results
(Group 2, control, n¼50) in the absence of known clinical and angiographic risk
factors for restenosis development. Baseline angiographic data of patients and im-
mediate results of PCI were evaluated by two independent experts. The standard
Sulphadimine was used as the test-agent. After single peroral intake of 500 mg of
Sulphadimine, the urine has been collected for 6 hours, and than the ratio of pro-
metabolized (N-acetyl-sulphadimine) and non-metabolized sulphadimine in urine was
determined with the help of high-effective liquid chromatography.
Results: Among the studied patients, there were 38% slow acetylators and 62% fast
acetylators. The analysis of the distribution of acetylation phenotype on groups 1 and
2 revealed high statistically signiﬁcant prevalence of fast acetylators among patients
with in-stent stenosis in the mid-term after PCI, P¼0,0006.
Conclusion: We revealed reliable direct correlation between the velocity of acetyla-
tion processes and the degree of in-stent stenosis after coronary stenting with BMS in
patients with chronic coronary heart disease.
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Background: Iatrogenic aortocoronary dissection is a rare but potentially disastrous
complication of percutaneous coronary intervention (PCI). However, there is a paucity
of data on the optimal initial management of this complication.The aim of this study
was to depict the characteristics and causes of iatrogenic aortocoronary dissection and
to elucidate the importance of a new strategy based on immediate bail-out stenting.
Methods: We collected 18 cases of iatrogenic aortocoronary dissection during PCI in
8 cardiac catheterization centers between 2005 and 2013, which were managed by a
single senior operator. A “4S” law based on immediate bail-out stenting performed
within 15 min was the initial strategy in most cases. The characteristics, treatment, and
in-hospital outcomes of the patients were evaluated.
Results: According to the NHLBI classiﬁcation, 15 patients (83.3%) had extensive
dissection (Type D to F) with acute closure (Type F) in 4 patients. In 3 patients
(16.7%), the dissections were diagnosed during coronary angiography, and in 15
patients (83.3%), during PCI. From the 18 patients, 16 patients (88.9%) underwent
bail-out stent implantation, with technical success in 14 patients. Among them, 13
patients followed the “4S” law, with 7.7  3.2 min from onset of dissection to
completion of bail-out stenting, and the procedural success rate was 100% with no
deaths. Two patients died due to time delay (stenting > 15min) and the third one died
due to hemodynamic collapse because the guidewire failed to cross the true lumen.
Conclusion: This study indicated that the “4S” law based on immediate bail-out
stenting is a feasible and efﬁcient strategy for the management of iatrogenic aorto-
coronary dissection.
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Background: Obesity is a well-known risk factor of cardiovascular disease. However,
several reports demonstrated “obesity paradox”, while central obesity was associated
with the highest risk of mortality, which suggests the signiﬁcance of visceral fat
measurement. Recently, a novel system with dual bioelectrical impedance analysis
(HDS-2000, Omron healthcare, Kyoto) was developed. This technique does not need
radiation exposure and the measurements were validated to have a good correlation
with computed tomography.
Methods: A total of consecutive 60 patients (69.3  10.6 years old, male 80%)
admitted to the department of cardiology were measured their visceral fat areas with
dual bioelectrical impedance analysis. Control group included 23 healthy volunteers
(31.5  8.3 years old, male 57%).
Results: The values of body mass index (24.0  4.6 vs 21.6  2.6, p¼0.03) and
visceral fat area (82.0  51.6 vs 46.1  15.7 cm2, p<0.01) in the hospitalized patientsApril 22–25, 2014 j TCTAP Abstracts/POSTER/Other (Unclassiﬁed)
